ATHENS, Ohio--(BUSINESS WIRE)--Diagnostic HYBRIDS announced today that it has executed a technology transfer and supply agreement with KaLy-Cell, S.A.R.L. (Besançon, France) for the manufacturing and distribution of hepatocytes and sub-cellular fractions from humans and several large and small animal species. The agreement also allows the companies to perform collaborative research and development activities to enhance their joint product offerings.
